Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis.

Shah RV, Allison MA, Lima JA, Bluemke DA, Abbasi SA, Ouyang P, Jerosch-Herold M, Ding J, Budoff MJ, Murthy VL.

Atherosclerosis. 2015 Sep;242(1):211-7. doi: 10.1016/j.atherosclerosis.2015.07.018. Epub 2015 Jul 15.

2.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.

Am Heart J. 2015 Mar;169(3):387-395.e3. doi: 10.1016/j.ahj.2014.12.018. Epub 2015 Jan 6.

3.

Pitavastatin in cardiometabolic disease: therapeutic profile.

Masana L.

Cardiovasc Diabetol. 2013;12 Suppl 1:S2. doi: 10.1186/1475-2840-12-S1-S2. Epub 2013 May 30. Review.

4.

Statins in cardiometabolic disease: what makes pitavastatin different?

Ginsberg H.

Cardiovasc Diabetol. 2013;12 Suppl 1:S1. doi: 10.1186/1475-2840-12-S1-S1. Epub 2013 May 30. Review.

5.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

6.

Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.

Davidoff A, Lopert R, Stuart B, Shaffer T, Lloyd JT, Shoemaker JS.

Value Health. 2012 May;15(3):404-11. doi: 10.1016/j.jval.2012.01.008. Epub 2012 Apr 10.

7.

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.

Wright AD, Dodson PM.

Eye (Lond). 2011 Jul;25(7):843-9. doi: 10.1038/eye.2011.62. Epub 2011 Mar 25. Review.

8.

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ.

J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205. doi: 10.1016/j.jacc.2008.10.031.

9.

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins.

Tenenbaum A, Fisman EZ, Motro M, Adler Y.

Cardiovasc Diabetol. 2006 Sep 26;5:20. Review.

Supplemental Content

Loading ...
Support Center